- Home
- NWFL vs CMPX Comparison
NWFL vs CMPX Comparison
Compare NWFL & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWFL
- CMPX
- Stock Information
- Founded
- NWFL 1870
- CMPX 2014
- Country
- NWFL United States
- CMPX United States
- Employees
- NWFL N/A
- CMPX N/A
- Industry
- NWFL Major Banks
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- NWFL Finance
- CMPX Health Care
- Exchange
- NWFL Nasdaq
- CMPX Nasdaq
- Market Cap
- NWFL 245.3M
- CMPX 291.8M
- IPO Year
- NWFL 1998
- CMPX N/A
- Fundamental
- Price
- NWFL $26.62
- CMPX $3.68
- Analyst Decision
- NWFL Buy
- CMPX Strong Buy
- Analyst Count
- NWFL 3
- CMPX 7
- Target Price
- NWFL $28.50
- CMPX $14.71
- AVG Volume (30 Days)
- NWFL 23.8K
- CMPX 885.5K
- Earning Date
- NWFL 10-27-2025
- CMPX 11-11-2025
- Dividend Yield
- NWFL 4.65%
- CMPX N/A
- EPS Growth
- NWFL N/A
- CMPX N/A
- EPS
- NWFL 0.37
- CMPX N/A
- Revenue
- NWFL $53,958,000.00
- CMPX N/A
- Revenue This Year
- NWFL $80.10
- CMPX N/A
- Revenue Next Year
- NWFL $28.45
- CMPX N/A
- P/E Ratio
- NWFL $72.84
- CMPX N/A
- Revenue Growth
- NWFL N/A
- CMPX N/A
- 52 Week Low
- NWFL $21.25
- CMPX $1.27
- 52 Week High
- NWFL $34.50
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- NWFL 57.80
- CMPX 65.31
- Support Level
- NWFL $26.18
- CMPX $3.48
- Resistance Level
- NWFL $26.97
- CMPX $3.77
- Average True Range (ATR)
- NWFL 0.51
- CMPX 0.18
- MACD
- NWFL -0.07
- CMPX 0.01
- Stochastic Oscillator
- NWFL 44.09
- CMPX 82.29
About NWFL Norwood Financial Corp.
Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.